• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

    2/14/24 5:04:07 PM ET
    $SFE
    Finance/Investors Services
    Finance
    Get the next $SFE alert in real time by email
    SC 13G/A 1 d768860dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2

    (Amendment No. 5)*

     

     

    Safeguard Scientifics, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    786449207

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    * 

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 786449207    13G    Page 1 of 5

     

     1.   

     NAMES OF REPORTING PERSONS

     

     Thomas A. Satterfield, Jr.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

     SOLE VOTING POWER

     

     400,000

       6.   

     SHARED VOTING POWER

     

     1,689,726

       7.   

     SOLE DISPOSITIVE POWER

     

     400,000

       8.   

     SHARED DISPOSITIVE POWER

     

     1,689,726

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     2,089,726

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

     12.61%*

    12.  

     TYPE OF REPORTING PERSON

     

     IN

     

    *

    Based on 16,575,618 shares of common stock of the issuer outstanding as of October 30, 2023, as reported by the issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023.


    CUSIP No. 786449207    13G    Page 2 of 5

     

    SCHEDULE 13G

     

    Item 1.

     

      (a)

    Name of Issuer:

    Safeguard Scientifics, Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    100 Matsonford Road

    One Radnor Corporate Center, Suite 110

    Radnor, Pennsylvania 19087

     

    Item 2.

     

      (a)

    Name of Person Filing:

    Thomas A. Satterfield, Jr.

     

      (b)

    Address of Principal Business Office or, if none, Residence:

    Thomas A. Satterfield, Jr.

    15 Colley Cove Drive

    Gulf Breeze, Florida 32561

     

      (c)

    Citizenship:

    Incorporated by reference from Item 4 of the Cover Page.

     

      (d)

    Title of Class of Securities:

    Incorporated by reference from the Cover Page.

     

      (e)

    CUSIP Number:

    Incorporated by reference from the Cover Page.

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or §§ 240.13d-2(b) or (c), check whether the person filing is a:

    Not Applicable.

     

    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned:

    Incorporated by reference from Item 9 of the Cover Page.

     

      (b)

    Percent of class:

    Incorporated by reference from Item 11 of the Cover Page.


    CUSIP No. 786449207    13G    Page 3 of 5

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote

    Incorporated by reference from Item 5 of the Cover Page.

     

      (ii)

    Shared power to vote or to direct the vote

    Incorporated by reference from Item 6 of the Cover Page.

     

      (iii)

    Sole power to dispose or to direct the disposition of

    Incorporated by reference from Item 7 of the Cover Page.

     

      (iv)

    Shared power to dispose or to direct the disposition of

    Incorporated by reference from Item 8 of the Cover Page.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    With respect to the beneficial ownership reported for Thomas A. Satterfield, Jr., 125,000 shares are held jointly with Rebecca S. Satterfield, Mr. Satterfield’s spouse; 250,000 shares are held by Tomsat Investment & Trading Co., Inc., a corporation controlled by Mr. Satterfield and of which he serves as President; 671,671 shares are held by Caldwell Mill Opportunity Fund, which fund is managed by an entity of which Mr. Satterfield owns a 50% interest and serves as Chief Investment Manager; and 360,000 shares are held by A.G. Family L.P., a partnership managed by a general partner controlled by Mr. Satterfield.

    Additionally, Mr. Satterfield has limited powers of attorney for voting and disposition purposes with respect to the following shares: Satterfield Vintage Investments LP (50,000 shares); Thomas A. Satterfield, Sr. (100,000 shares); Rebecca A. Satterfield (25,000 shares); Jeanette Satterfield Kaiser (16,500 shares); Richard W. Kaiser (15,000 shares); Henry Beck (7,500 shares); George and Laura Thaggard Pontikes (40,555 shares); Milyn Satterfield Little (2,000 shares); Parker Little Trust (2,500 shares); Lola Ann Little Trust (1,000 shares); Riachuello Ranch LLC (1,000 shares); Christy Beard (4,000 shares); Pamela Beck (2,000 shares); John and Angela Picton (16,000 shares); Milyn Satterfield Little (2,000 shares); and Pontikes Holdings LP (40,555 shares). These individuals and entities have the right to receive or the power to direct the receipt of the proceeds from the sale of their respective shares.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not Applicable.


    CUSIP No. 786449207    13G    Page 4 of 5

     

    Item 8.

    Identification and Classification of Members of the Group.

    Not Applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not Applicable.

     

    Item 10.

    Certifications.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP No. 786449207    13G    Page 5 of 5

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    February 14, 2024
    Date
    /s/ Thomas A. Satterfield, Jr.
    Thomas A. Satterfield, Jr.
    Get the next $SFE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SFE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SFE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Safeguard Scientifics Filed Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC

      RADNOR, Pa., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it filed Form 25 with the Securities and Exchange Commission (the "SEC") to voluntarily delist its shares of common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq") in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and to delist the Company's common stock from trading on Nasdaq (referred to as the "Transaction"). The Company expects that the delisting will occur ten days after the filing of Form 25 so that trading will be suspended

      2/2/24 8:30:00 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Intends to File Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC

      Radnor, Pa, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it notified The Nasdaq Stock Market LLC ("Nasdaq") that it intends to file Form 25 with the Securities and Exchange Commission (the "SEC") on February 2, 2024 to voluntarily delist its shares of common stock from trading on Nasdaq in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company expects that the delisting will occur ten days after the filing of Form 25, at which point, the Company intends to file a Form 15 with the SEC certifying

      1/22/24 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Effective Date of Stock Splits to Effectuate the Going Dark Transaction and New Chief Executive Officer and Chief Financial Officer

      RADNOR, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, as authorized by its Board of Directors (the "Board"), the Company will file amendments to its articles of incorporation with the Pennsylvania Department of State to effectuate a reverse stock split at a ratio of 1-for-100, to be followed immediately by a forward stock split at a ratio of 100-for-1 (collectively referred to as "stock splits"), which are expected to become effective on or about January 12, 2024, and the Company's common stock is expected to begin trading on The Nasdaq Stock Market LLC ("Nasdaq") on a post-forward stock split basis upon

      1/5/24 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/14/24 5:04:07 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/14/24 4:05:40 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/12/24 4:59:41 PM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    SEC Filings

    See more
    • SEC Form 15-12G filed by Safeguard Scientifics Inc.

      15-12G - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)

      2/20/24 3:02:10 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13E3/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13E3/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/20/24 3:01:28 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form EFFECT filed by Safeguard Scientifics Inc.

      EFFECT - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)

      2/20/24 12:15:21 AM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Manko Joseph M. Jr. was granted 38,087 shares, increasing direct ownership by 20% to 232,323 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      2/1/24 2:36:21 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Demont Ross D was granted 20,775 shares, increasing direct ownership by 8% to 287,256 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      1/31/24 9:19:37 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • Michelson Beth was granted 22,506 shares, increasing direct ownership by 22% to 126,352 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      1/31/24 9:09:45 AM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Financials

    Live finance-specific insights

    See more
    • Safeguard Scientifics Announces Stock Split Ratios to Effectuate the Going Dark Transaction

      RADNOR, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, after the Company's shareholders adopted amendments to the articles of incorporation at the Special Meeting of Shareholders held on December 15, 2023 (the "Special Meeting") to effect a reverse stock split, to be followed immediately by a forward stock split, at a ratio of (i) not less than 1-for-50 and not greater than 1-for-100, in the case of the reverse stock split, and (ii) not less than 50-for-1 and not greater than 100-for-1, in the case of the forward stock split (collectively referred to as "stock splits"), the Company's Board of Directors (t

      12/18/23 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics' Board of Directors Declares Contingent Cash Dividend of $0.35 Per Share

      RADNOR, Pa., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that on December 7, 2023, its Board of Directors (the "Board") declared a special cash dividend of $0.35 per share, payable on December 28, 2023 to shareholders of record as of the close of business on December 19, 2023 (the "Record Date"). The dividend is contingent on the adoption of amendments to the Company's articles of incorporation effecting the reverse stock split and the forward stock split of the Company's common stock at the Special Meeting of Shareholders to be held on December 15, 2023, and the Board thereafter giving effect to the Company's

      12/8/23 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Third Quarter 2023 Financial Results

      RADNOR, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.7 million at September 30, 2023.The carrying value of the Company's ownership interests totaled $14.8 million at September 30, 2023. The total cost of the Company's ownership interests was $122.8 million.Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, as compared with a net loss of $3.2 million, or $0.19 per bas

      11/2/23 4:30:03 PM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Leadership Updates

    Live Leadership Updates

    See more
    • TheracosBio Announces the Appointments of Jim Greenwood to Board of Directors and Jeff McGroarty as Chief Financial Officer

      TheracosBio today announced the appointment of former US Congressman Jim Greenwood to the Board of Directors of its parent company and Jeff McGroarty, MBA, as its Chief Financial Officer. Congressman Greenwood is an established leader in life sciences across business and public policy, and Mr. McGroarty has served as a CFO of public and private life sciences and technology companies. Both newly appointed team members will help shape the commercial strategy for Brenzavvy™ (bexagliflozin), a recently FDA-approved treatment for type 2 diabetes. "Accomplished leaders, Jim and Jeff will be valuable members of our team at this critical time for TheracosBio," said Albert R. Collinson, Ph.D., Pres

      3/13/23 8:00:00 AM ET
      $ANVS
      $SFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Appointment Of Eric C. Salzman As CEO

      RADNOR, Pa., Dec. 21, 2020 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE:SFE) announced today that Eric C. Salzman has been appointed Chief Executive Officer, effective December 21, 2020.  Since April 1, 2020, Mr. Salzman has served as the Company's Chief Restructuring Officer. As CEO, Mr. Salzman will continue to focus on the value maximization and monetization of Safeguard's interests in its portfolio companies as well as the management of Safeguard's operations. "Since joining Safeguard earlier this year, we have been impressed with Eric's progress towards executing on Safeguard's strategy to drive value creation from the portfolio and return capital to our shareholders," said Robe

      12/21/20 8:00:00 AM ET
      $SFE
      Finance/Investors Services
      Finance